Latest Breaking News On - Maryland based cellular - Page 1 : comparemela.com

AstraZeneca starts the Cellectis partnership with $105 million in upfront cash and an equity investment. The pharmaceutical giant will also cover research costs for up to 10 cell therapy programs in oncology, immunology, and rare diseases.

London
City-of
United-kingdom
Rockville
Maryland
United-states
Marc-dunoyer
Servier-pharmaceuticals
Astrazeneca
Astrazeneca-rare-disease
Neogene-therapeutics
Maryland-based-cellular